Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro … F Hamdan, E Ylösmäki, J Chiaro, Y Giannoula, M Long, M Fusciello, ... Journal for Immunotherapy of Cancer 9 (8), 2021 | 39 | 2021 |
Cellular senescence and the host immune system in aging and age-related disorders Y Giannoula, G Kroemer, F Pietrocola biomedical journal 46 (3), 100581, 2023 | 27 | 2023 |
Genomic characterization of lymphomas in patients with inborn errors of immunity X Ye, PJ Maglione, C Wehr, X Li, Y Wang, H Abolhassani, E Deripapa, ... Blood Advances 6 (18), 5403-5414, 2022 | 23 | 2022 |
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses F Hamdan, B Martins, M Feodoroff, Y Giannoula, S Feola, M Fusciello, ... Molecular Therapy-Methods & Clinical Development 20, 625-634, 2021 | 11 | 2021 |
The dual role of CD70 in B‐cell lymphomagenesis M Nie, W Ren, X Ye, M Berglund, X Wang, K Fjordén, L Du, Y Giannoula, ... Clinical and Translational Medicine 12 (12), e1118, 2022 | 7 | 2022 |